No Detail Found!

Molecular and serological assessment of chronic hbv carriers and additional burden of applying updated guidelines in Pakistan.

Author(s)
Agha Babar Hussain Department of Virology, Armed Forces Institute of Pathology (AFIP), Rawalpindi, Pakistan
Syed Azhar Ahmed Baqai Medical University, Karachi, Pakistan
Farooq Ahmad Khan Department of Chemical Pathology Armed Forces Institute of Pathology (AFIP), Rawalpindi, Pakistan
Eijaz Ghani Department of Virology, Armed Forces Institute of Pathology (AFIP), Rawalpindi, Pakistan
Muhammad Ali Rathore Department of Virology, Armed Forces Institute of Pathology (AFIP), Rawalpindi, Pakistan
Nadir Ali Department of Haematology Armed Forces Institute of Pathology (AFIP), Rawalpindi, Pakistan
Abstract
Objective: To assess the additional burden of the patients eligible for treatment, based on recommendations on viral load, in the light of 2009 version of AASLD guidelines, as compared to 2004 guidelines and to determine the frequency of HBeAg in chronic HBV carriers. Study design: Descriptive cross-sectional study. Place and duration of study: Virology Department, Armed Forces Institute of Pathology, Rawalpindi, from November 2010 to January 2012. Methodology: Persons with chronic HBV infection, reporting for HBV DNA PCR test, were included in the study and blood samples were collected. HBV DNA load was determined by Real Time PCR. HBsAg and HBeAg were tested by ELISA. Results: Out of the 801 subjects positive for HBsAg, 74 (9.24%) were positive for HBeAg. Out of them, 113 (14.1%) had HBV DNA load > 100,000 copies/ml and were eligible for treatment according to AASLD 2004 guidelines. Forty one (5.1%) had HBV load between 10,000 and 100,000 copies/ml, and were additionally eligible for treatment as per AASLD 2009 guidelines. The 5.1% of 4.5 million estimated HBV carries in Pakistan comes to 229500. Conclusion: There was a low HBeAg positivity and HBV DNA positivity in our chronic HBV infected persons. Moreover, there is an increase of 229500 potential candidates for HBV treatment in Pakistan based on viral load testing, according to the AASLD 2009 guidelines when compared with 2004 guidelines. The increase in the number of candidates for treatment may require an additional expenditure of tens of billions of rupees.
Publication Details
Page(s) 620-623
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 24, Issue: 9, Year: 2014

Request the full text from PASTIC

0

Citations

0

Downloads

77

Views